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FRETn one receptor plus degrading enzymes for adenine nucleotides or nucleosides,
and cellular responses to purines are rarely compatible with the actions of single receptors. Therefore, these
receptors are viewed as components of a combinatorial receptor web rather than self-dependent entities, but
it remained unclear to what extent they can associate with each other to form signalling units. P2Y1, P2Y2,
P2Y12, P2Y13, P2X2, A1, A2A receptors and NTPDase1 and -2 were expressed as ﬂuorescent fusion proteins
which were targeted to membranes and signalled like the unlabelled counterparts. When tested by FRET
microscopy, all the G protein-coupled receptors proved able to form heterooligomers with each other, and
P2Y1, P2Y12, P2Y13, A1, A2A, and P2X2 receptors also formed homooligomers. P2Y receptors did not associate
with P2X, but G protein-coupled receptors formed heterooligomers with NTPDase1, but not NTPDase2. The
speciﬁcity of prototypic interactions (P2Y1/P2Y1, A2A/P2Y1, A2A/P2Y12) was corroborated by FRET competition
or co-immunoprecipitation. These results demonstrate that G protein-coupled purine receptors associate
with each other and with NTPDase1 in a highly promiscuous manner. Thus, purinergic signalling is not only
determined by the expression of receptors and enzymes but also by their direct interaction within a
previously unrecognized multifarious membrane network.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionExtracellular adenine nucleosides and nucleotides are involved in a
plethora of physiological and pathophysiological functions such as
muscle contraction, platelet aggregation, cell proliferation, chemosen-
sory signalling, immune and inﬂammatory responses, and neuro-
transmission. These actions are mediated by two separate families of
membrane receptors named P1 and P2. P1 receptors are those for
adenosine and can be subdivided in A1, A2A, A2B, and A3 receptors all of
which are heptahelical receptors typically coupled to heterotrimeric
GTP binding proteins [1,2]. P2 receptors comprise two different
subgroups: P2X receptors are ATP-gated cation channels composed
of three out of a set of at least 7 different subunits [3]; P2Y receptors are
heptahelical G protein coupled receptors (GPCRs) and at least 8
different subtypes have been identiﬁed so far (P2Y1, P2Y2, P2Y4, P2Y6,
P2Y11, P2Y12, P2Y13, P2Y14) [4]. In addition, a separate class of receptors
has been proposed to exist and to accept nucleosides as well as
nucleotides as agonists [5,6], and this class was suggested to be named
P3 [7]. However, the existence of this latter type of receptors has not
been conﬁrmed by molecular means.Medical University of Vienna,
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l rights reserved.Most of the receptors mentioned above display a rather wide-
spread distribution in mammals. In particular, A1 and A2A, as well as
P2Y1, P2Y2, P2Y6, P2Y13, and P2Y14 receptors are expressed in quite a
number of different tissues, whereas the other receptors show a more
restricted expression pattern [2,4]. P2X receptors, for example, are
conﬁned to excitable tissues and some hemopoietic and epithelial
cells (North, 2002). Thus, most mammalian cells do express by far
more than one of the receptors that are activated by adenine
nucleosides or nucleotides. Moreover, the functional responses to
various nucleotides and nucleosides as observed in many tissues are
not entirely compatible with the pharmacological characteristics of a
single cloned receptor [8]. Therefore, Volonte et al. [9] suggested to
regard single receptors for nucleotides as part of a “combinatorial
receptor web”.
Extracellular nucleosides and nucleotides are found in virtually all
types of tissues as they are released from a large variety of cells. One
obvious reason for the presence of nucleosides and nucleotides in the
extracellular space is cell damage. In addition, release of adenosine
may occur through various transporters present in the plasma
membrane [2]. Nucleotides, in contrast, are released either through
vesicle exocytosis from neurons and neuroendocrine cells or via
largely unidentiﬁed mechanisms from all other types of cells [10].
However, the extracellular concentrations of adenosine, AMP, ADP,
and ATP do not only depend on the release of each of the various
species, but are also regulated by various enzymes which mediate the
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in the extracellular space. The initial reactions are provided by families
of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and
ecto-nucleotide pyrophosphatase/phosphodiesterases some of which
are integral membrane proteins. The ﬁnal step leading to nucleosides
is mainly catalyzed by ecto-5′-nucleotidase which is either mem-
brane-associated via a GPI anchor or soluble. Like P1 and P2 receptors,
these enzymes display a rather widespread expression pattern and
most cells harbor more than one representative [11].
In many tissues, the actions of endogenous nucleotides are indirect
ones and involve not only receptors, but also degrading enzymes. In
hippocampal neurons, for instance, adenine nucleotides are rapidly
converted to adenosinewhich activates inhibitory A1 receptors [12]. In
hepatoma cells [13], ATP is degraded to ADP to stimulate P2Y1
receptors. In osteoblastic [14] and epithelial [15] cells, however, ATP
itself activates P2Y2 and P2Y11 receptors, respectively. In neuroendo-
crine cells, direct and indirect effects of ATP occur in parallel via P2Y2
and P2Y12 receptors, respectively [16]. Hence, a localization of
enzymes in close proximity to certain receptors can be expected to
underlie indirect effects of nucleotides.
In order to provide a basis for the proposed “combinatorial
receptor web” [9] as well as for enzyme-dependent indirect nucleo-
tide effects, we investigated the possibilities of associations between
different P1 and P2 receptors as well as membrane NTPDases by FRET
microscopy. The results reveal that a large number of combinations
may occur to form a membrane network of receptors and enzymes for
adenine nucleosides and nucleotides.
2. Materials and methods
2.1. Cell culture and transfection
Human embryonic kidney (HEK) 293 cells, tsA 201 cells (a subclone
of HEK 293 cells stably expressing the SV40 large T-antigen), and
human astrocytoma 1321N1 cells were cultured in Dulbecco's
modiﬁed Eagle's medium (PAA Laboratories, Pasching, Austria)
containing 1 g l−1 glucose and L-glutamine, supplemented with 10%
fetal bovine serum (PAA) and 25,000 IU l−1 penicillin and 25 mg l−1
streptomycin (Sigma, Vienna, Austria). For NTPDase activity measure-
ments, cells were seeded in uncoated 24 multiwell plates (about
25,000 cells per well). For Ca2+ ﬂuorescence determinations, cells
were plated in 96 well plates (about 8000 cells per well) coated with
bovine gelatine. For patch-clamp experiments, cells were plated in
35 mm culture dishes coated with rat tail collagen as described [17].
For FRET microscopy, cells were plated on poly-D-lysine-coated glass
cover slips. All cells were transfected using the ExGen 500 reagent
(Fermentas; St.Leon-Rot, Germany) according to the manufacturer's
recommendation. 3 μg DNA in total were transfected and FRET
measurements were carried out 24 h later.
P2X2-CFP/-YFP were a kind gift of Dr. Florentina Soto (Seattle, USA),
A1-CFP/-YFP were kindly donated by Dr. Rafael Franco (Barcelona,
Spain; [18]), and A2A-CFP/-YFP, FLAG-tagged and non-tagged A2A by
Dr. Oliver Kudlacek (Vienna, Austria). To generate fusion proteins of rat
P2Y receptors with CFP (P2Y-CFP) at their C-termini, DNA fragments
encoding the full length P2Y receptors were obtained using Taq
polymerase (Fermentas). The forward primers were used to add an
XhoI restriction site upstream of the start codon, and the reverse
primer omitted the stop codon and added an EcoRI site. The PCR
ampliﬁcation products were digested with the corresponding restric-
tion enzymes and ligated in-frame in the pECFP-N1 vector (Becton
Dickinson, Heidelberg, Germany). A plasmid containing eNTPDase1
fused to CFP and YFP at the N-terminus was constructed using PCR
ampliﬁcation of the full length cDNA. The forward primer was used to
introduce an XhoI site and omit the start codon, and the reverse
primer added an EcoRI site. The PCR product was ligated in-frame in
the pECFP-C1 and pEYFP-C1 vector. NTPDase2 was cut out of thepEGFP-C1 vector with BglI and XhoI and ligated in-frame in vector
pEYFP-C1 with the same restriction sites to create NTPDase2 fused to
YFP at the N-terminus. cDNAs for rat eNTPDase1 and eNTPDase2 were
kindly provided byHerbert Zimmermann (Frankfurt, Germany), for rat
P2Y1 by Georg Reiser (Magdeburg, Germany), for rat P2Y2 by Tania
Webb (Leicester, UK), for rat P2Y12 by Eric Barnard (Cambridge, UK).
The rat P2Y13 sequence was obtained from PC12 cells by RT-PCR using
primers that were predicted to amplify sequences that are identical or
similar to regions of identity in the human and mouse P2Y13 DNAs.
The PCR products with appropriate lengths (951 and 800 bp,
respectively) were sequenced and found to be identical with a
sequence predicted to code for rat P2Y13 (XM-227178) which was
corroborated later by expression cloning [19]. The integrity of all
generated constructs was veriﬁed by sequence analysis.
2.2. Determination of NTPDase activity
NTPDase activity was determined using a Malachite Green
Phophatase Assay Kit (BioAssaySystems, Hayward, CA, USA) according
to the manufacturer's recommendations. Either untransfected tsA 201
cells or cells transiently expressing untagged or YFP-tagged NTPDase1
or -2 were used for these experiments 48 h after transfection. Cells
were incubated in a buffer (in mM: NaCl 150, KCl 4, CaCl2 2, MgCl2 2,
glucose 10, HEPES 10) containing 30 μM ATP, 30 μM ADP, or no
nucleotides for 10 min at 36 °C. Then, the supernatant was withdrawn
and an aliquot (160 μl) was mixed with the malachite green reagent
(40 μl) to assay for released phosphates. The optical densities of these
mixtures were quantiﬁed at a wavelength of 620 nm using 96 well
plates positioned in a microplate reader (Victor3, PerkinElmer,
Waltham, MA, USA). From these optical density values, nucleotide
concentrations were calculated using a calibration curve obtained
with dilutions of a phosphate standard solution.
2.3. Determination of cyclic AMP
The accumulation of cyclic AMP was determined in HEK 293 cells
24 h after transfection of A2A receptors by a technique described in
detail elsewhere [20]. After incubation in medium containing 2.5 μCi
ml−1 tritiated adenine for 12 h, the medium was replaced by a buffer
(120 mM NaCl, 3 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 20 mM glucose,
10mMHEPES, adjusted to pH 7.4with NaOH) containing 100 μMof the
phosphodiesterase inhibitor Ro-20-1724 [4-(3-butoxy-4-methoxy-
benzyl) imidazolidin-2-one] and 1 U ml−1 adenosine deaminase.
Dishes were then kept at room temperature for about 90 min. The A2A
receptor agonist CGS 21680 was added and the cultures were
incubated for additional 15 min at room temperature. Finally, the
buffer was replaced by 1 ml of 2.5% perchloric acid containing 100 μM
non-labelled cyclic AMP followed by a 20 minute incubation at 4 °C.
In experiments addressing the signalling of P2Y13, 1321N1
astrocytoma cells were transfected with plasmids coding for human
β2 adrenoceptors (provided by M. Lohse Wuerzburg), on one hand,
and for untagged or YFP-tagged P2Y13 receptors, on the other hand
(200 ng each per well). Loading with tritiated adenine and subsequent
manipulations were performed as above. During the last 15 min, the
buffer contained 10 μM of the β adrenergic agonist isoproterenol, in
the absence or presence of 10 nM ADP.
Cyclic AMP was separated from the other purines by a two column
chromatographic procedure as described [20]. One tenth of each
sample obtained as described abovewas used for the determination of
the total radioactivity. The remaining 900 μl was neutralised by
addition of 100 μl 4.2 M KOH and applied to Dowex 50 columns (AG
50W-X4; Bio-Rad, Vienna, Austria) which were then rinsed with 3 ml
H2O. The eluate obtained by the subsequent application of 8 ml H2O
was directly poured onto alumina columns (Bio-Rad, Vienna, Austria),
which were then washed with 6 ml H2O. Finally, cyclic AMP was
eluted with 4 ml imidazole buffer (20 mM imidazole in 0.2 M NaCl;
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by liquid scintillation counting. The radioactivity in the fraction of
cyclic AMP was expressed as percentage of the total radioactivity
incorporated in the cells.
2.4. Ca2+ mobilization assay
HEK293 and 1321N1 astrocytoma cells were transfected with
plasmids coding for untagged or CFP-tagged P2Y1, P2Y2, and P2Y12
(200 ng each per well). Since activation of the Gi coupled P2Y12
receptor is not efﬁciently linked to Ca2+ mobilization, a chimeric G-
protein (Gqi-top; kindly provided by J.P. Pin) that redirects signalling
towards phospholipase C was coexpressed with this latter receptor.
Twenty four hours after transfection, experiments were performed
using a FLEX Station II (Molecular Devices, Sunnyvale, CA, USA).
Before, cells were incubated for 60 min in buffer (as above) containing
the Ca2+ reporter (FLIPR calcium 4 assay kit, Molecular Devices) and
were then transferred directly to the plate reader. Prior to ﬂuorescence
determinations, light absorbance by the Ca2+ reporter-labelled cells
was quantiﬁed as a measure of culture density. Fluorescence
excitation and emission wavelengths were set to 485 nm and
525 nm, respectively. Substances were applied via a built in pipetting
device. The ﬂuorescence signal was measured at a sampling frequency
of 0.67 Hz for 20 s before and for 100 s after drug application. In order
to directly compare the results of different wells, the relative
ﬂuorescence units (RFU) obtained were divided by the light
absorbance of the respective culture; this procedure sets the
ﬂuorescence values in relation to the number of cells in the dish
(normalized response). Nucleotide-induced responses were calcu-
lated as follows: RFU(max)-RFU(bkgr), where RFU(max) resembles
the maximal response in the time window 40 s after stimulation and
RFU(bkgr) the background ﬂuorescencewithout stimulation 20 s prior
to stimulation.
2.5. Electrophysiology
Whole-cell currents induced by the application of ATP were
recorded at room temperature (20–24 °C) from tsA 201 cells 24 to 48 h
after transfectionwith either P2X2-YFP or untagged P2X2 as described
elsewhere [21]. Currents were registered via an Axopatch 200B
ampliﬁer and the Pclamp 8.0 hard- and software (Molecular Devices,
MDS Sciex, Concord, ON, Canada), low-pass ﬁltered at 5 kHz, digitized
at 10 kHz, stored, and analyzed off-line by the Clampﬁt program
(Axon). Patch electrodes were pulled (Flaming-Brown puller, Sutter
Instruments, Novato, CA, USA) from borosilicate glass capillaries
(Science Products, Frankfurt/Main, Germany) and ﬁlled with a
solution consisting of (mM) KCl (140), CaCl2 (1,6), HEPES (10),
Mg-ATP (2), adjusted to pH 7.3 with KOH, to yield tip resistancies of
2 to 3MΩ. The external bathing solution consisted of (mM) NaCl (140),
KCl (3), MgCl2 (2), CaCl2 (2.5), glucose (10), HEPES (10), adjusted to pH
7.3 with KOH. Drugs were applied via a DAD-12 drug application
device (Adams & List, Westbury, NY, USA) which permits a complete
exchange of solutions surrounding the cells under investigation
within less than 100 ms [17].
2.6. FRET microscopy
Three ﬁlter FRET experiments [22] were carried out in tsA 201 cells
24 h after transfectionwith a total of 3 μg DNA per cell culture using an
inverted ﬂuorescence microscope (Zeiss), a mercury arc lamp (Zeiss
HBO 100-watt intensity) and an 63× Zeiss oil immersion objective. For
detection of CFP, cells were viewed with a ﬁlter set with an excitation
ﬁlter of 440 nm, a dichroic beam splitter of 455 nm, and an emission
ﬁlter of 480 nm. The ﬁlter set for YFP consisted of an excitation ﬁlter of
500 nm, a dichroic beam splitter of 525 nm, and an emission ﬁlter of
535 nm. The ﬁlters for FRET were an excitation ﬁlter of 440 nm, adichroic beam splitter of 455 nm, and an emission ﬁlter of 535 nm.
Images were captured with a cooled CCD camera (Roper Scientiﬁc,
coolsnap fx) and were analyzed with the Metamorph software
(Molecular Devices).
FRET with the three-ﬁlter set system was quantiﬁed according to
the method introduced by Xia and Liu [23] to normalize the FRET
intensity to CFP and YFP concentrations in each region of interest
(ROI). ROIs were selected manually and represent membranes
expressing both FRET partners. For an ROI, intensity (I) from
the three ﬁlter sets was obtained after background subtraction.
Then, NFRET was calculated as follows: NFRET=(IFRET− IYFP×a− ICFP×b) /
square root (IYFP× ICFP), where a=23%, which is the percentage of CFP
contribution to FRET intensity, and b=67%, which is the percentage of
YFP contribution to FRET intensity.
In each experiment, mean NFRET values of 5 to 8 ROIs were
obtained, and arithmetic means of at least 3 independent experiments
are shown for each data point. Analysis of statistically signiﬁcant
differences was performed by one-way ANOVA followed by Bonferro-
ni's Multiple Comparison Test, and p valuesb0.05 were considered
indicative of statistically signiﬁcant differences.
2.7. Immunoprecipitation and Western blotting
tsA 201 cells were solubilized 48 h after transfection in lysis buffer
containing 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 50 mM
Tris–HCl (pH 8.0) and proteinase inhibitor cocktail (Roche, Mannheim,
Germany) on a shaker for 30 min at 4 °C. After centrifugation at
12,000 ×g for 10 min at 4 °C, the supernatant was incubated overnight
without or with afﬁnity puriﬁed mouse anti-FLAG M2 monoclonal
antibody (Sigma, Vienna, Austria) and subsequently incubated with
protein G beads for 4 h at 4 °C. After six washes with lysis buffer,
bound proteins were eluted in SDS sample buffer at 55 °C for 12 min.
Eluted proteins were separated on SDS polyacrylamide gels and
transferred to polyvinylidene ﬂuoride membranes (Waters, Milford,
MA, USA) which were then stained with anti-FLAG M2 antibody
(1:800) and rabbit anti-GFP polyclonal antibody (1:5000; Abcam,
Cambridge, UK), respectively.
3. Results
Fluorescence resonance energy transfer microscopy has been used
to study interactions between a number of transmembrane proteins
such as GPCRs [24] and ligand-gated ion channels [25]. In our
laboratories, we have successfully applied this method to study the
oligomerization of transporters [26] and decided to extend this
procedure to investigate interactions between various transmem-
brane proteins that bind extracellular adenine nucleotides or nucleo-
sides. To this end, we generated fusion proteins with CFP and/or YFP of
the following receptors, subunits or enzymes: rat P2Y1 (P2Y1-C and
P2Y1-Y), rat P2Y2 (P2Y2-C), rat P2Y12 (P2Y12-Y and P2Y12-C), rat P2Y13
(P2Y13-C), rat eNTPDase1 (NTPD1-C and NTPD1-Y), and rat eNTPDase2
(NTPD2-Y). In addition, P2X2-CFP/-YFP, A1-CFP/-YFP and A2A-CFP/-YFP
were obtained from external sources. Before testing for interactions
between these ﬂuorescent membrane fusion proteins, their proper
membrane expression and functions were investigated in functional
experiments.
3.1. Functional characteristics of ﬂuorescent NTPDases
To learn whether fusion of ﬂuorescent proteins to the N-termini of
NTPDases might inﬂuence membrane targeting or functions of the
enzymes, tagged and non-tagged NTPDases 1 and 2 were expressed in
tsA 201 cells. The release of phosphates from ADP or ATP in the
medium surrounding these cells was quantiﬁed as a measure for
enzyme activity. Results obtained with transfected cells were
compared with those from non-transfected cells. As shown in Fig. 1,
Fig. 2. Currents mediated by YFP-tagged and non-tagged P2X2 receptors. A shows
original traces of ATP-evoked currents. 30 μM ATP was applied (as indicated by the grey
bars) to tsA 201 cells either expressing YFP-tagged P2X2 receptor subunits (P2X2-YFP) or
wild-type P2X2 receptor subunits (P2X2-WT), both clamped at a holding potential of
−70 mV. The inset depicts the current amplitudes elicited by 30 μM ATP (n=4 to 5).
⁎ indicates a signiﬁcant difference versus P2X2-YFP at pb0.05 (unpaired Student's
T-test). B shows concentration response curves for currents evoked by the ATP
concentrations indicated (n=6). For each cell, all amplitudes were normalized to that
evoked by 1 mM ATP (I / I1000 μM); calculated EC50 values were 5.5 μM (P2X2-YFP) and
7.9 μM (P2X2-WT), respectively (pN0.05).
Fig. 1. Hydrolysis of ATP and ADP by YFP-tagged and non-tagged NTPDases. tsA 201 cells transiently expressing either YFP-tagged or non-tagged NTPDase-1 or -2 were incubated in
the absence or presence of 30 μM ATP (left) or ADP (right) for 10 min at 36 °C. The amount of phosphate released into the buffer was quantiﬁed using a malachite green assay. All the
corresponding values obtained with the YFP-tagged and the non-tagged versions of the enzymes, respectively, were not signiﬁcantly different from each other at pb0.05 (n=8 to 12;
unpaired Student's T-test).
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the release of substantial amounts of phosphates from solutions
containing 30 μM ADP and ATP, respectively (pN0.05 vs solutions
containing no nucleotides). In contrast, in cells expressing NTPDases 1
or 2, whether tagged or untagged, signiﬁcantly more phosphate was
retrieved when ATP was present in the extracellular medium
(pb0.001 in all cases). With ADP, the situation was different:
signiﬁcantly more phosphate (pb0.005) was found in the nucleo-
tide-containing solution only when incubated cells expressed
NTPDase1, but not when cells expressed NTPDase2 (Fig. 1). This
corroborates that NTPDase2 preferentially degrades ATP over ADP
[27].
Irrespective of whether the expressed enzyme was NTPDase1 or 2,
all values obtained with the YFP fusion proteins were not signiﬁcantly
different from the results with untagged enzymes (Fig. 1). Thus, the
ﬂuorescent ectonucleotidases were targeted to the membrane as their
unmodiﬁed counterparts and operated in a comparable manner.
3.2. Functional characteristics of ﬂuorescent P1 and P2 receptors
To investigate whether the functions of P1 (adenosine) receptors
might be affected by the attached ﬂuorescent proteins, A2A receptors
were expressed either as untagged proteins, as C-terminal fusion
proteins with YFP or endowed with N-terminal FLAG tags. After
loading with [3H] adenine, the amount of radioactivity within the
cyclic AMP pool was 0.040±0.008% of the total radioactivity in
untransfected cells, 0.128±0.024 in A2A expressing cells, 0.082±0.010%
in A2A-FLAG expressing cells, and 0.146±0.022 in A2A-YFP expressing
cells (n=6). After incubation in 1 μM of the appropriate agonist CGS
21680 for 15 min, these values remained unchanged in untransfected
cells (1.04-fold of basal), but were raised 4.4-fold in A2A (pb0.001;
n=6), 2.21-fold in A2A-FLAG (pb0.001; n=6) and 2.68-fold in A2A-YFP
(pb0.01; n=6) expressing cells. Thus, the tagged versions of the A2A
receptor were all able to mediate the generation of cyclic AMP in
response to an according agonist, although they appeared to be less
active than the untagged receptor.
To reveal whether the ﬂuorescent proteins might interfere with
the membrane expression and function of P2X receptors, YFP-tagged
and non-tagged P2X2 subunits were expressed in tsA 201 cells, and
current responses were investigated in whole-cell patch-clamp
recordings. As shown in Fig. 2, the kinetics of ATP-evoked currents
through both types of receptors were similar, but amplitudes of ATP-
induced currents were signiﬁcantly larger in cells expressing P2X2-YFPthan in cells expressing untagged P2X2 (Fig. 2A). The most likely
explanation for this observation is the following: with P2X2-YFP,
nicely ﬂuorescent cells were chosen for experimentation, whereas
P2X2 expressing cells were chosen randomly. Thus, with the
ﬂuorescent subunits, the results are biased towards highly expressing
cells. Nevertheless, the concentration response curves obtained with
ﬂuorescent and non-ﬂuorescent receptors were not signiﬁcantly
Fig. 3. Functional responses of CFP-tagged and non-tagged P2Y receptors.1321N1 astrocytoma cells were either transfected with plasmids coding for CFP-tagged or non-tagged P2Y1,
P2Y2, or P2Y12 receptors; in the latter case, cells were cotransfected with a plasmid coding for the chimeric G-protein α subunit Gqi-top. Cultures were then labelled with the FLIPR
calcium 4 assay kit and the ﬂuorescence signal was determined for periods of 120 s; nucleotides were applied after 20 s. Maximal values of normalized responses (see Materials and
methods) obtained during the application of the nucleotides are shown (n=10 to 16 for P2Y1, 12 to 15 for P2Y2, and 6 to 8 for P2Y12).
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P2X2 subunits are expressed at the cell membrane and their functions
are similar to those of non-ﬂuorescent subunits.
In order to evaluate the functions of membrane P2Y receptors in a
quantitative manner, agonist-dependent increases in intracellular
Ca2+ concentrations were determined. For the Gq-coupled receptors
P2Y1 and P2Y2, this is a natural signalling cascade. For the Gi linked
P2Y12 receptor, however, receptor activationwas rerouted to increases
in intracellular Ca2+ by co-expression of the chimeric G protein αq
subunit Gqitop [28]. To ensure that signals obtainedwith recombinant
receptors are not tampered by endogenous nucleotide responses, HEK
293 cells not expressing recombinant P2Y receptors were exposed to
ADP and ATP. Whether these cells were expressing chimeric G
proteins or not, the nucleotides triggered signiﬁcant increases in
intracellular Ca2+ (not shown). Therefore, the rat astrocytoma cell line
N321N1 was chosen as alternative expression system for functional
experiments, as the nucleotides did not evoke signiﬁcant increases in
intracellular Ca2+ concentrations in these cells as long as they did not
express recombinant P2Y receptors (not shown).
In order to compare the functions of ﬂuorescently tagged P2Y
receptors with those of their non-tagged counterparts, both forms of
P2Y1, P2Y2, and P2Y12 receptors were transiently expressed in N321N1
cells, either alone or together with Gqitop. When activated by
appropriate agonists, the ﬂuorescently- and non-tagged versions of
these three receptors mediated virtually identical Ca2+signals (Fig. 3).
Hence, the ﬂuorescent fusion proteins of these P2Y receptors do not
differ signiﬁcantly from their non-ﬂuorescent counterparts, neither in
membrane expression nor in signal transduction.
The Gi-coupled P2Y13 receptor was tested for functionality using
N321N1 cells again, but by determining its effect on the accumulation
of cyclic AMP triggered via co-transfected β2 adrenoceptors [20]. The
isoproterenol-induced cyclic AMP accumulation was reduced by
10 nM ADP in P2Y13 expressing cells by 24.7±6.2% (pb0.05 vs
control; n=12) and in P2Y13-CFP expressing cells by 26.5±5.0%
(pb0.05 vs control; n=12). Thus, the ﬂuorescent P2Y13 receptor
mediated inhibition of adenylyl cyclase as did its non-tagged
counterpart.
3.3. Validation of FRET measurements by well documented interactions
Although FRET measurements are very speciﬁc in terms of
determining distances between adjacent ﬂuorescent proteins, the
differences in arbitrary ﬂuorescence values are small and may be
affected by systematic errors [29]. Therefore, we gauged our system by
comparison of the present results with previously published positive
and negative controls. As ﬁrst example, we used the human serotonin
transporter (SERT) which homooligomerizes in plasma membranes;
the speciﬁcity of this interactionwas documented by showing that the
human SERT did not oligomerize with human D2 dopamine receptors
[30]. Accordingly, in the present experiments high NFRET values were
obtained when CFP- and YFP-tagged SERTs were co-expressed in HEK293 cells (0.176±0.017; n=3). In contrast, the NFRET values obtained
after co-expression of YFP-tagged D2 receptors and CFP-tagged SERTs
(0.077±0.014; n=3) were indistinguishable from the values ob-
tained after co-expression of the two ﬂuorescent moieties only
(0.063±0.013; n=7; Fig. 4D). Nevertheless, in overlays of the
ﬂuorescent micrographs obtained with wavelengths exciting either
CFP or YFP, an unequivocal co-localization of either the two differently
tagged SERTs or CFP-SERT and YFP-D2 within the plasma membrane
was observed (Fig. 4A). Hence, all the ﬂuorescent proteins were
present in the membrane, but only the interacting ones gave high
NFRET values.
To further validate our NFRET value determinations, YFP-D2 was
expressed together with a CFP-tagged humanmetabotropic glutamate
receptor 5 (mGluR5). Again, the NFRET values (0.081±0.009; n=3)
were not different from those obtained with the two ﬂuorescent
moieties only. In contrast, co-expression of CFP- and YFP-tagged
versions of mGluR5 resulted in NFRET values (0.175±0.031; n=3) as
high as those obtained with the two differently tagged SERTs (Fig. 4E).
These results are in line with previous FRET experiments and conﬁrm
that mGluR5 is able to homo-oligomerize in the plasma membrane,
but unable to closely associate with D2 receptors [31].
Amongst the purinergic receptors, P2X receptor subunits are
known to form homomeric or heteromeric trimers [3], and direct
contact between P2X2 subunits in the plasma membrane has been
documented via FRET microscopy [25]. Although our functional
experiments clearly indicated that P2X2-YFP is targeted to the
membrane (Fig. 2), we ﬁrst established that the two differently
labelled P2X2 subunits are co-localized in the plasma membrane by
confocal laser microscopy (Fig. 4B). Then, ﬂuorescence micrographs
were taken with ﬁlter combinations to selectively visualize the
localization of CFP, YFP, or the potentially occurring FRET interaction
(Fig. 4C). Finally, using the ﬂuorescent CFP- and YFP-micrographs
corrected for the bleed-through errors, a virtual NFRET micrograph was
calculated and is depicted in Fig. 4C. In line with this calculated
micrograph, NFRET values for co-expressed CFP- and YFP-tagged P2X2
subunits as determined in membrane regions (0.183±0.008; n=7)
were in the same range as those for the differently tagged SERTs and
mGluRs (Fig. 4D).
P2X2 subunit containing receptors are mainly expressed in the
nervous system [3], and their proper function relies on the presence
of NTPDase1 [32]. Therefore, we tested whether co-expression of
YFP-tagged NTPDase1 with CFP-tagged P2X2 subunits might result in
NFRET values indicative of a close association of these two proteins in
the plasma membrane. However, the values were not different from
those obtained with the two ﬂuorescent moieties only and were in
the same range as those for YFP-D2 plus CFP-SERT and YFP-D2 plus
CFP-mGluR5, respectively (Fig. 4D). Nevertheless, YFP-tagged
NTPDase1 and CFP-tagged P2X2 subunits were colocalized in the
plasma membrane as evidenced by confocal microscopy (Fig. 4B), but
gave no positive FRET images or visible signals in the calculated NFRET
micrograph (Fig. 4C).
Fig. 4. Validation of FRET measurements by well documented interactions. A shows
pseudocolour representations of ﬂuorescent micrographs of the human serotonin
transporter fused to CFP (SERT-C) or YFP (SERT-Y) and the human D2 dopamine receptor
fused to YFP (D2-Y). The right hand micrographs show overlays of the two pictures to
the left. B shows pseudocolour representations of ﬂuorescent confocal laser scanning
micrographs of the P2X2 subunit fused to CFP (P2X2-C) or YFP (P2X2-Y) and NTPDase1
fused to YFP (NTPD1-Y). In addition, a membrane staining by trypan blue is depicted.
The right hand micrographs show overlays of the three pictures to the left. Note the
white lining of the membrane region where the subsequent FRET measurements were
performed. C shows pseudocolour representations of ﬂuorescent micrographs of the
same fusion proteins as in B. The next twomicrographs to the right show the respective
FRET pictures and the calculated NFRET pictures. D depicts NFRET values obtained with
the fusion proteins mentioned above and with mGluR5 fused to CFP (mGluR5-C) or YFP
(mGluR5-Y), YFP-tagged NTPDase2 (NTPD2-Y), and CFP or YFP. ⁎⁎ and ⁎⁎⁎ indicate
signiﬁcant differences versus the values obtained with CFP and YFP at pb0.01 and
pb0.001, respectively (n=3 to 8).
Fig. 5. Interactions between GPCRs for adenine nucleotides and nucleosides revealed by
FRET microscopy. A shows ﬂuorescent micrographs of P2Y13 receptors fused to CFP
(P2Y13-C) or YFP (P2Y13-Y) and A1 receptors fused to YFP (A1-Y). B to D depict NFRET
values obtained with the fusion proteins mentioned above and with A2A, P2Y1, P2Y2,
P2Y12 fused to either CFP or YFP. The values obtained with P2X2-C plus P2X2-Y and
P2X2-C plus NTPD1-Ywereused as positive and negative controls, respectively. ⁎, ⁎⁎, and
⁎⁎⁎ indicate signiﬁcant differences versus the values obtained with P2X2-C plus NTPD1-
Yat pb0.05, pb0.01, and pb0.001, respectively (n=3 to 6 in B, 3 to 10 in C, and 3 to 7 in D).
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YFP-tagged NTPDase2, and the results were comparable with those for
NTPDase1 plus P2X2 (Fig. 4D). In all future FRET experiments, thecombinations P2X2-C plus P2X2-Y and P2X2-C plus NTPD1-Y were
used for statistical comparisons as prototypic examples of membrane
protein pairs that give high and low NFRET values, respectively.
Fig. 6. Adenosine A2A receptor interaction with P2Y1 and P2Y12 revealed by co-
immunoprecipitation. tsA 201 cells transiently expressing A2A-FLAG together with
either P2Y1-CFP, P2Y12-CFP or pECFP-N1 (empty vector) were solubilized (Input) and
immunoprecipitated (IP) with (+) or without (−) anti-FLAG monoclonal antibody.
Immunoprecipitated A2A receptor was visualized in immunoblots (IB) using an anti-
FLAG antibody (lower panel) and co-puriﬁed P2Y1 and P2Y12 were detected with anti-
GFP polyclonal antibody (upper panel). The numbers refer to the positions of pre-
stained molecular weight markers. The lanes shown in the lower panel were derived
from one single gel with different exposure time.
Fig. 7. Interactions between NTPDases and receptors for adenine nucleotides and
nucleosides revealed by FRETmicroscopy. A and B depict NFRET values obtained with the
fusion proteins mentioned in the previous ﬁgures. ⁎⁎ and ⁎⁎⁎ indicate signiﬁcant
differences versus the values obtained with P2X2-C plus NTPD1-Y at pb0.01 and
pb0.001 (n=3 to 17 in A and 3 to 18 in B), respectively. C depicts NFRET values obtained
with P2Y1 receptors fused to CFP (P2Y1-C) or YFP (P2Y1-Y) and with NTPDase2 fused to
YFP (NTPD2-Y). In addition, unlabelled P2Y1 or NTPDase2 were expressed together with
these fusion proteins where indicated. ⁎⁎⁎ indicates signiﬁcant differences versus the
values obtained with P2Y1-C plus P2Y1-Y at pb0.001 (n=3); n.s. indicates the lack of
such a signiﬁcance.
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P2Y receptors
To reveal whether ionotropic and metabotropic receptors for
adenine nucleotides are able to closely associate in cell membranes,
P2Y1, P2Y2, P2Y12, and P2Y13 receptors with CFP attached to their
C-termini were co-expressed with P2X2-Y as mentioned above.
The NFRET values obtained with these pairs of fusion proteins
were 0.057±0.018, 0.062±0.015, 0.061±0.016, 0.083±0.009, and
0.057±0.018 (n=3 in each case). All these values were not signiﬁcantly
different from the results obtained with P2X2-C plus NTPD1-Y
(0.077±0.005; n=8) in parallel experiments, but signiﬁcantly smaller
than the values obtained with P2X2-C plus P2X2-Y (0.166±0.008;
n=8).
3.5. Promiscuous interactions between P1 and P2Y receptors
To evaluate whether the various GPCRs for adenine nucleosides or
nucleotides are able to closely associate in cell membranes in a homo-
or heteromeric manner, ﬂuorescently tagged versions of adenosine
and P2Y receptors were expressed in a pair wise manner. For all of
these proteins the proper insertion in the membrane has been
evidenced by functional experiments either shown above, or (for A1
receptors) in previous experiments [18]. For this latter receptor and for
P2Y13, Fig. 5A exempliﬁes membrane localization, and the FRET
micrograph documents close association. In fact, the NFRET values
obtained for all the pairs of ﬂuorescently labelled GPCRs were
signiﬁcantly different from the results obtained with P2X2-C plus
NTPD1-Y in parallel experiments, but not from those obtained with
P2X2-C plus P2X2-Y (Fig. 5B–D). Moreover, coexpression of fusionproteins of A1, A2A, P2Y1 P2Y12 and P2Y13 receptors containing the two
different ﬂuorescent moieties, respectively, also resulted in NFRET
values signiﬁcantly different from the negative (P2X2-C plus
NTPD1-Y), but not from the positive (P2X2-C plus P2X2-Y) controls.
Thus, all the GPCRs for adenine nucleosides and nucleotides displayed
propensities to oligomerize in the membranes.
3.6. Interactions between GPCRs revealed by co-immunoprecipitation
To corroborate the above FRET data by a completely independent
method, two pairs of heterologously expressed receptors were
investigated by co-immunoprecipitation. As we had found A2A
receptors and P2Y12 receptors to be expressed together in PC12 cells
and sympathetic neurons and to functionally interact at the level of
their associated signalling cascades [33], we decided to use this pair as
a ﬁrst prototypic example. Therefore, A2A-FLAG was co-expressed in
tsA 201 cells either with P2Y12-CFP or with the empty CFP vector.
Solubilized proteins were precipitated via an anti-FLAG antibody and
Table 1
Summary of interactions as deﬁned by obtained NFRET values in comparison with the
values for the positive and negative controls, respectively
P2X2 NTPDase1 NTPDase2 P2Y1 P2Y2 P2Y12 P2Y13 A1 A2A
P2X2 + − − n.a. n.a. n.a. n.a. n.a. n.a.
NTPDase1 − + + + + + + + +
NTPDase2 − + n.a. − − − − − −
P2Y1 n.a. + −⁎ +⁎ + + + + +§
P2Y12 n.a. + − + + + + + +§
P2Y13 n.a. + − + + + + + +
A1 n.a. + − + + + + + +
A2A n.a. + − +§ + +§ + + +
+, NFRET values not different from those for P2X2-C/P2X2-Y; −, NFRET values not different
from those for P2X2-C/NTPD1-Y; n.a., not analyzed; ⁎, result conﬁrmed by FRET
competition; §, result conﬁrmed by co-immunoprecipitation.
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Fig. 6, bands of approximately 55 kDa and 43 kDawere detected when
P2Y12-CFP was expressed together with the A2A receptor, but not
when the pECFP-N1 vector had been used instead. Nevertheless, in
both cases the anti-FLAG antibody efﬁciently precipitated the A2A
receptor, and omission of this antibody ruled out the precipitation of
P2Y1 or 12-CFP by non-speciﬁc binding to beads. In order to
corroborate an interaction of A2A receptors with a Gq-coupled P2Y
receptor, these experimentswere repeatedwith P2Y1 instead of P2Y12.
Nevertheless, the results obtained were the same (Fig. 6). Thus,
interactions as revealed by FRETmicroscopy can also be demonstrated
via co-immunoprecipitation.
3.7. Interactions between P1/P2Y receptors and NTPDases
Although neither NTPDase1 nor 2 was found to interact with P2X2
subunits, we co-expressed ﬂuorescent versions of these enzymes
together with the ﬂuorescent GPCRs mentioned above, again in a pair
wise manner. As shown in Fig. 7, NFRET values obtained with NTPDase1
co-expresssed with P1 or P2Y receptors were signiﬁcantly different
from the negative control values (P2X2-C plus NTPD1-Y). In contrast,
NTPDase1 expressed together with an unrelated GPCR, namely
mGluR5, yielded NFRET values that were not different from those for
P2X2-C plus NTPD1-Y. Co-expression of NTPDase1 fusion proteins
containing the two diverging ﬂuorescent moieties, however, resulted
in NFRET values signiﬁcantly different from the chosen negative
controls (Fig. 7A). Similarly, co-expression of NTPDase1 and 2 with
diverging ﬂuorescent residues led to NFRET values also signiﬁcantly
different from those for P2X2-C plus NTPD1-Y. Together with all of the
P1 or P2Y receptors, however, NTPD2-Y failed to achieve NFRET values
different from those for P2X2-C plus NTPD1-Y. Hence, the two
NTPDase isoforms differed in their tendencies to closely associate
with purine receptors.
To conﬁrm that interactions observed by FRET microscopy as
described above are speciﬁc, we performed competition experiments
challenging the homomeric interaction of P2Y1 receptors. When
P2Y1-C and P2Y1-Y were coexpressed together with non-tagged P2Y1,
the NFRET values were signiﬁcantly reduced. When these experiments
were repeated with non ﬂuorescent NTPDase2 instead of P2Y1,
however, there was no signiﬁcant change in the NFRET values for
coexpressed P2Y1-C and P2Y1-Y (Fig. 7C). Hence, interactions revealed
by FRET microscopy as above, can only be disrupted by appropriate
interaction partners, but not by membrane proteins that were not
interacting according to the NFRET values obtained.
4. Discussion
While ionotropic receptors have long been known to be composed
by several subunits, the formation of homo- and heteromers by GPCRs
has been detected more recently [34]. In this respect, ionotropic and
metabotropic receptors for adenine nucleosides and nucleotides are
no exception. P2X receptors exist as trimers [3], and in the recent past
several adenosine and/or P2Y receptors have been detected to form
homo- and heterodimers [35]. Here, FRET microscopy, one of the
methodsmost frequently used for the detection of oligomer formation
between GPCRs [24,29], has been used to demonstrate that receptors
for adenine nucleosides and nucleotides may form a large variety of
different oligomers which, in addition, can also include enzymes for
nucleotide degradation.
Although FRETmicroscopy has been used to identify the formation
of GPCR oligomers for a large number of receptor pairs, the results
obtained by this technique must be interpreted cautiously to account
for potential artefacts [24,29] as follows. The fusion of ﬂuorescent
proteins to GPCRs may alter membrane targeting and signalling
properties of GPCRs as evidenced, for instance, for P2Y1 receptors [36].
Therefore, the fusion proteins of A2A, P2X2, P2Y1, P2Y2, P2Y12, P2Y13,NTPDase1 and NTPDase2 were tested for their functional properties in
comparisonwith their untagged counterparts. After expression, all the
fusion proteins were found to signal in a manner similar to that of the
untagged versions. Thus, all the ﬂuorescent proteins employed herein
were positively tested for functionality with the exception of A1,
results on which have been published before [18].
Having established that functional ﬂuorescent proteins do reach
the membrane, this targeting was corroborated by confocal laser
microscopy for two prototypic examples (P2X2 and NTPDase-1). Using
the pairs P2X2-C/P2X2-Y and P2X2-C/NTPD1-Y, we then established
that these can be used as positive and negative controls, respectively,
for the following reasons: (i) P2X2 has previously been documented to
oligomerize in the membrane [25]. (ii) NFRET values obtained with
P2X2-C/P2X2-Y were identical with those obtained for two entirely
independent pairs of membrane proteins, namely CFP- and YFP-
labelled human SERT and mGluR5, which had also been shown to
homooligomerize in cell membranes [30,31]. (iii) NFRET values
obtained with P2X2-C/NTPD1-Y in the membrane were not different
from those obtained with only the ﬂuorescent moieties, but the latter
were determined in cytosolic regions. (iv) NFRET values for P2X2-C and
NTPD1-Y were also identical with the NFRET values for unrelated pairs
of ﬂuorescent membrane proteins that had been established not to
interact with each other elsewhere [30,31]. Thus, the above results
which we have used as reference values are in perfect agreement with
previous data.
FRET microscopy on ﬂuorescent membrane proteins does, of
course, rely on the evaluation of recombinant instead of native
proteins, and therefore overexpression is a frequently mentioned
concern, as exaggerated overexpression can be expected to force
membrane proteins to directly interact with each other. Moreover,
overexpression might lead to the presence of membrane proteins in
membrane compartments in which they would not be located under
native conditions. On the other hand, the HEK 293 cells used as host
system do express endogenous P2Y receptors at unknown levels.
Therefore, reliable positive and negative controls must be established
for each of the ﬂuorescent proteins being investigated to certify that
the fusion proteins do not lead to apparently positive FRET values by a
default mechanism. In Table 1, all the positive interactions as deﬁned
by highNFRET values are listed together with all the negative results for
all pairs of proteins investigated. A look at this table reveals that none
of the fusion proteins employed gave either negative or positive
results only. Hence, in no case the presence or absence of interactions
with other membrane proteins appeared to be a default mechanism.
To further conﬁrm the speciﬁcity of positive interactions, a FRET
competition assay was performed as frequently recommended for
FRET investigations of GPCRs [29]. In fact, an appropriate unlabelled
interaction partner (P2Y1) reduced the NFRET values obtained with
P2Y1-C and P2Y1-Y, whereas a non-interacting protein (NTPDase2)
failed to do so. Moreover, two of the direct interactions (A2A and P2Y1
or P2Y12) as determined via FRETmicroscopy were corroborated by an
entirely independentmethod, namely co-immunoprecipitation. Taken
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deﬁned by FRET microscopy are not artefactual.
Table 1 reveals that particularly the GPCRs for adenine nucleosides
and nucleotides display a high tendency to form homo-as well as
heterooligomeric complexes in the membrane. Previously, only single
examples of interactions between adenosine and/or P2Y receptors
have been identiﬁed; these were A1 and A2A [18], A1 and P2Y1 [37], A1
and P2Y2 [38], P2Y1 and P2Y11 [39], and P2Y4 and P2Y6 [40]. The ﬁrst
three of these examples are corroborated by the present data, and
another 12 previously unknown heteromeric interactions are
described for the ﬁrst time. In addition, homomeric assemblies have
been reported for a number of GPCRs for purines, including A2A [41],
P2Y1 [42], P2Y2 [43], P2Y12 [44], as well as P2Y4 and P2Y6 [40]. Here, all
the GPCRs tested for homooligomeric assemblies (A1, P2Y1, P2Y12,
P2Y13) were found to closely associate in the membrane. Taken
together, the GPCRs that accept adenine nucleosides or nucleotides as
agonists form not only homooligomers, but also heterooligomers, and
the receptors associate in a pairwise manner in all combinations that
can be imagined.
Most cell types express more than one receptor for purines and the
responses of cells to applied nucleotides are most frequently
incompatible with the activation of one or several independent
molecularly deﬁned receptor types [8]. As shown here, GPCRs for
purines tend to form oligomers, and oligomer formation is known to
affect trafﬁcking, ligand binding, signalling and desensitization of
GPCRs [34]. Thus, the functions of adenosine and P2Y receptors in a
given cell do not only depend on the presence of the respective GPCR,
but also on the co-expression of one or more of the other receptor
types. Hence, the idea of viewing receptors for purines primarily as
components of a “combinatorial receptor web” [9] is supported by the
present data which reveal a plethora of combinatorial possibilities.
Furthermore, the multifarious combinations between P2Y and
adenosine receptors provide an explanation for common effects
elicited by nucleosides and nucleotides which had been suggested to
be mediated by a separate class of receptors designated as P3 [7].
The concept of a combinatorial receptor web is even further
extended by results obtained with the two major representatives of
themembrane-bound NTPDases, namely NTPDase1 and -2.While P2X
did not associate with one of these enzymes, all the GPCRs for purines
were found to interact with NTPDase1, but not with NTPDase2.
NTPDase2 is an enzyme that generates potential P2Y receptor agonists
as it hydrolyzes ATP towards ADP, whereas NTPDase1 rather degrades
P2Y receptor agonists by converting ATP and ADP towards AMP [11].
Thus, the P2Y receptors are associated with an enzyme that can be
expected to remove the agonist and which was shown to reduce or
even prevent desensitization of P2Y receptors [27]. In line with the
close association between P2Y receptors and NTPDase1 as observed
here, the co-expression of P2Y1 together with NTPDase1 affected
concentration response curves for receptor agonists in the same way
as expression of a P2Y1/NTPDase1 fusion protein when both were
compared with the expression of the receptor only [27,45]. Given that
P2Y receptors interact with NTPDase1, why don't P2X receptors do so,
even though the proper function of P2X receptors requires the
expression of NTPDase1 [32]? NTPDases display Km values for
nucleotides in the low micromolar range [11], whereas EC50 values
at P2Y receptors are in the nanomolar range [4] and those at P2X
receptors are again in the micromolar range [46]. Thus, a close
association between NTPDases and P2X receptors must be expected to
either attenuate or even prevent activation of the ionotropic receptors
by ATP due to competition by the enzyme. In addition, the NTPDase1
associated with P2Y receptors can be viewed as a device that drains off
nucleotides from P2X receptors expressed on the same cell to
simultaneously provide P2Y receptors with appropriate concentra-
tions of agonist.
In conclusion, the present data show that GPCRs for adenine
nucleosides and nucleotides can associate either as homomers or in apair wise manner in more than 10 different heteromeric combina-
tions. Furthermore, these GPCRs can associate with NTPDases as
shown for NTPDase1 here. Thus, the physiological effects of adenine
nucleotides and nucleosides rather rely on a membrane network of
appropriate receptors and enzymes than on the presence of isolated
proteins; depending on the partners included in the network, a
previously unforeseen number of different responses can be expected
to arise in response to ATP, ADP, and adenosine.
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